Acurastem received a grant to develop ALS therapies targeting SYF2, a regulator of TDP-43, in collaboration with academic ...

Veteran journalist Oren Nahari revealed he has ALS, a severe degenerative neurological disease. How many Israelis are ...

Mike Trujillo believed he had found a cure for his condition when he went for stem cell treatment. He couldn't have been more ...

Keros lines up 2026 catalysts with rinvatercept at the core, including a Q2 DMD phase II start and ALS regulatory plans as execution shifts into focus.

Researchers at Case Western Reserve University found evidence that gut bacteria may contribute to brain damage in Amyotrophic ...

In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 ...

L-leucine, an FDA-approved compound, exerts neuroprotective effects in Parkinson’s disease models. By reducing ...

Paradromics announced today that it kicked off a new partnership program to open collaboration on brain-computer interface (BCI) technology.

A deep-dive tribute into the life of Jamie Dunn, the voice of Agro and a legend of Australian radio, celebrating his multifaceted career and community impact. Australian actress Lorraine Bayly AM, ...

Brother and brother in law of Donato and Mary Cirocco (both dec) Carmela and Mario Greco ( both dec) Lino and Antonietta ...

Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular ...